Tat-CBD3A6K (trifluoroacetate salt)

Formulation: A solid

Formal Name: L-tyrosylglycyl-L-arginyl-L-lysyl-L-lysyl-L-arginyl-L-arginyl-L-glutaminyl-L-arginyl-L-arginyl-L-arginyl-L-alanyl-L-arginyl-L-seryl-L-arginyl-L-leucyl-L-lysyl-L-α-glutamyl-L-leucyl-L-arginylglycyl-L-valyl-L-prolyl-L-arginylglycyl-L-leucine, trifluoroacetate salt

Purity: ≥95%

Formula Markup: C137H250N60O32 • XCF3COOH

Formula Weight: 3249,8

Shelf life (days): 1460

Notes: Tat-CBD3A6K is a peptide and derivative of the N-type voltage-gated calcium channel Cav2.2 and collapsin response mediator protein 2 (CRMP2) protein-protein interaction inhibitor Tat-CBD3 (Item No. 37448).{69499,69500} Tat-CBD3A6K (10 mg/kg) prevents decreases in the paw withdrawal threshold in a rat model of antiretroviral neuropathic pain induced by d4T (stavudine; Item No. 14975) and decreases the number of action potentials from dorsal root ganglia (DRG) neurons isolated from the same rats.{69499} Dural administration of Tat-CBD3A6K (30 µM/animal) decreases meningeal blood flow induced by the terpene alkaloid capsaicin (Item Nos. 92350 / 10010743) in rats.{69500}

• Artikelnummer: CAY37449-10
• Hersteller: Cayman Chemical
• Hersteller Artikelnummer: 37449-10
• Green Labware: Nein
• Verpackungseinheit: 10 mg
• Mengeneinheit: STK